May 2, 2010 / 6:23 PM / 10 years ago

J&J shares poised to gain-Barron's

NEW YORK, May 2 (Reuters) - Johnson & Johnson (JNJ.N) shares should rise 10 percent to 20 percent within a year or two from earnings growth, a strong product pipeline and a solid balance sheet, according to Barron’s May 3 edition.

Barron’s says that having survived a difficult 2009, the company’s main goal now is to boost sales.

Separately, Johnson & Johnson on Friday announced a recall of a host of infants and children’s medicines, including Children’s Tylenol and Zyrtec.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below